FDA nod for Novavax Covid vax with stricter new conditions
٦ مشاهدات
The FDA has approved the Novavax Covid 19 vaccine but with restrictions limiting its use to older adults and those over 12 with high risk medical conditions This decision follows debates among CDC advisors about targeting Covid shots to the most vulnerable The new limitations signal a potentially more restrictive approach from the FDA influenced by skepticism towards vaccines
